With gleevec coming off patent, the real concern is what's going to happen to margins in 2015. A CBO study conducted a few years back found that generic's reduce profit margins by an average of 12%.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.